Literature DB >> 27447457

[Strategies of age-adapted pharmacotherapy in renal failure].

R Lenssen1, A Liekweg2.   

Abstract

Many geriatric patients with multimorbidities have an increased risk for impaired renal function due to age and often the presence of comorbidities, such as diabetes mellitus, hypertension and heart failure. This impairment in kidney function in turn necessitates adjustments in drug therapy. A successful strategy for treating these patients includes treatment of the underlying diseases, a comprehensive review of the indications, selection of appropriate pharmacotherapeutic alternatives and for some drugs dose adjustment to the renal function. To achieve therapeutic success many patient individual factors, such as potentially complex medication regimens, polypharmacy, cognitive function and functional disabilities need to be considered when prescribing medications. This article describes the problems associated with drug therapy that is not adjusted to renal function and provides guidelines for assessment of the benefits and risks in patients with kidney failure. The characteristic features of geriatric patients in particular are considered and discussed.

Entities:  

Keywords:  Age; Dose adjustment; Geriatrics; Impaired renal function; Polypharmacy

Mesh:

Substances:

Year:  2016        PMID: 27447457     DOI: 10.1007/s00391-016-1111-4

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  21 in total

Review 1.  Medication issues in older individuals with CKD.

Authors:  Dena E Rifkin; Wolfgang C Winkelmayer
Journal:  Adv Chronic Kidney Dis       Date:  2010-07       Impact factor: 3.620

Review 2.  The frailty syndrome: definition and natural history.

Authors:  Qian-Li Xue
Journal:  Clin Geriatr Med       Date:  2011-02       Impact factor: 3.076

3.  Two novel equations to estimate kidney function in persons aged 70 years or older.

Authors:  Elke S Schaeffner; Natalie Ebert; Pierre Delanaye; Ulrich Frei; Jens Gaedeke; Olga Jakob; Martin K Kuhlmann; Mirjam Schuchardt; Markus Tölle; Reinhard Ziebig; Markus van der Giet; Peter Martus
Journal:  Ann Intern Med       Date:  2012-10-02       Impact factor: 25.391

4.  [Drug supply and patient safety in long-term care facilities for the elderly].

Authors:  T Uhrhan; M Schaefer
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2010-05       Impact factor: 1.513

Review 5.  [Anticoagulation in the elderly].

Authors:  J Harenberg; R Bauersachs; C Diehm; H Lawall; H Burkhardt; H Gerlach; H Darius; H Völler; E Rabe; M Wehling
Journal:  Internist (Berl)       Date:  2010-11       Impact factor: 0.743

6.  Potentially inappropriate medications in the elderly: the PRISCUS list.

Authors:  Stefanie Holt; Sven Schmiedl; Petra A Thürmann
Journal:  Dtsch Arztebl Int       Date:  2010-08-09       Impact factor: 5.594

Review 7.  Adverse drug events as a cause of hospitalization in older adults.

Authors:  Fabio Salvi; Annalisa Marchetti; Federica D'Angelo; Massimo Boemi; Fabrizia Lattanzio; Antonio Cherubini
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

8.  Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study.

Authors:  Sebastian Schneeweiss; Joerg Hasford; Martin Göttler; Annemarie Hoffmann; Ann-Kathrin Riethling; Jerry Avorn
Journal:  Eur J Clin Pharmacol       Date:  2002-06-12       Impact factor: 2.953

9.  Development of an adverse drug reaction risk assessment score among hospitalized patients with chronic kidney disease.

Authors:  Fatemeh Saheb Sharif-Askari; Syed Azhar Syed Sulaiman; Narjes Saheb Sharif-Askari; Ali Al Sayed Hussain
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

10.  Kidney function and clinical recommendations of drug dose adjustment in geriatric patients.

Authors:  Marlies Karsch-Völk; Elisa Schmid; Stefan Wagenpfeil; Klaus Linde; Uwe Heemann; Antonius Schneider
Journal:  BMC Geriatr       Date:  2013-09-10       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.